Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Hematologic Diseases
×
ibrutinib
×
Clear all
Filters
3
NCT05254743
2026-03-12
BRUIN-CLL-314
Eli Lilly and Company
Phase 3
Recruiting
662 enrolled
NCT04662255
2025-05-28
BRUIN-MCL-321
Eli Lilly and Company
Phase 3
Active not recruiting
500 enrolled